These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1776810)

  • 1. Plasma C1 inhibitor in malignant diseases: functional activity versus concentration.
    Starcević D; Jelić-Ivanović Z; Kalimanovska V
    Ann Clin Biochem; 1991 Nov; 28 ( Pt 6)():595-8. PubMed ID: 1776810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of C1-inhibitor functional activities by immunodiffusion assay in plasma of patients with hereditary angioedema--evidence of a functionally critical level of C1-inhibitor concentration.
    Späth PJ; Wüthrich B; Bütler R
    Complement; 1984; 1(3):147-59. PubMed ID: 6443347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.
    Cugno M; Nuijens J; Hack E; Eerenberg A; Frangi D; Agostoni A; Cicardi M
    J Clin Invest; 1990 Apr; 85(4):1215-20. PubMed ID: 2318974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.
    Woo P; Lachmann PJ; Harrison RA; Amos N; Cooper C; Rosen FS
    Clin Exp Immunol; 1985 Jul; 61(1):1-8. PubMed ID: 4042415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasma.
    Munkvad S; Jespersen J; Sidelmann J; Gram J
    Clin Chem; 1990 Jul; 36(7):1305-11. PubMed ID: 2372942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic inactivation of plasma C1- inhibitor in sepsis.
    Nuijens JH; Eerenberg-Belmer AJ; Huijbregts CC; Schreuder WO; Felt-Bersma RJ; Abbink JJ; Thijs LG; Hack CE
    J Clin Invest; 1989 Aug; 84(2):443-50. PubMed ID: 2668333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma.
    Munkvad S; Jespersen J; Gram J; Overgaard K; Rånby M
    Clin Chem; 1990 May; 36(5):737-41. PubMed ID: 2337981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1 inhibitor and diagnosis of hereditary angioedema in newborns.
    Nielsen EW; Johansen HT; Holt J; Mollnes TE
    Pediatr Res; 1994 Feb; 35(2):184-7. PubMed ID: 8165053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.
    Jackson J; Sim RB; Whaley K; Feighery C
    J Clin Invest; 1989 Feb; 83(2):698-707. PubMed ID: 2536404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional determination of C1 esterase inhibitor in fractions derived from plasma.
    Benny AG; Brimer CM
    Haematologia (Budap); 1989; 22(3):189-93. PubMed ID: 2583599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor.
    Schousboe I
    Eur J Biochem; 2003 Jan; 270(1):111-8. PubMed ID: 12492481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a plasma-derived C1 esterase inhibitor on hemostatic activation, clot formation, and thrombin generation.
    Levy JH; Szlam F; Gelone S
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):883-9. PubMed ID: 25222191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.
    Donaldson VH; Harrison RA; Rosen FS; Bing DH; Kindness G; Canar J; Wagner CJ; Awad S
    J Clin Invest; 1985 Jan; 75(1):124-32. PubMed ID: 3965500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro interaction of C1-inhibitor with thrombin.
    Cugno M; Bos I; Lubbers Y; Hack CE; Agostoni A
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):253-60. PubMed ID: 11460008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of C1 inhibitor.
    Davis AE
    Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1-esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsia.
    Halbmayer WM; Hopmeier P; Mannhalter C; Heuss F; Leodolter S; Rubi K; Fischer M
    Thromb Haemost; 1991 Feb; 65(2):134-8. PubMed ID: 2053098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
    Alsenz J; Loos M
    Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.